Literature DB >> 22828734

Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome.

P Lund1, P T Sangild, L Aunsholt, B Hartmann, J J Holst, J Mortensen, P B Mortensen, P B Jeppesen.   

Abstract

BACKGROUND/
OBJECTIVES: Colostrum is rich in immunoregulatory, antimicrobial and trophic components supporting intestinal development and function in newborns. We assessed whether bovine colostrum could enhance intestinal adaptation and function in adult short bowel syndrome (SBS) patients. SUBJECTS/
METHODS: Twelve SBS patients in this randomised cross-over study received 4 weeks oral supplement of bovine colostrum or an iso-energetic and iso-proteinaceous control (2.4 MJ/d, 500 ml/day) separated by a 4-week washout period. Patients were admitted four times for 72-h periods of fluid, electrolyte and nutrient balance studies. Meals, faeces and urine were weighed, and energy, macronutrient and electrolyte contents were analysed to calculate net nutrient uptake. Body composition was measured by dual-energy X-ray absorptiometry scans, and functional tests of handgrip strength and lung functions were performed. Eight patients completed the study and were included in the analysis.
RESULTS: Both supplements (colostrum and control) not only increased protein (0.96 ± 0.42 MJ/d, P=0.004 1.03 ± 0.44 MJ/d, P=0.003) and energy (1.46 ± 1.02 MJ/d, P=0.005, 1.76 ± 1.46 MJ/d, P=0.01) absorption but also absolute faecal wet weight excretions (231 ± 248 g/d, P=0.002, 319 ± 299 g/d, P=0.03), compared with baseline measurements. Both supplements improved handgrip strength (P=0.03) while only the control supplement increased lean body mass (1.12 ± 1.33 kg, P<0.049). Colostrum was not found to be superior to the control.
CONCLUSION: Intake of high-protein milk supplements increased net nutrient absorption for adult SBS patients, but at the expense of increased diarrhoea. Despite high contents of bioactive factors, colostrum did not significantly improve intestinal absorption, body composition or functional tests compared with the control.

Entities:  

Mesh:

Year:  2012        PMID: 22828734     DOI: 10.1038/ejcn.2012.93

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  7 in total

Review 1.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

2.  Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice.

Authors:  Iulia Elena Filipescu; Leonardo Leonardi; Laura Menchetti; Gabriella Guelfi; Giovanna Traina; Patrizia Casagrande-Proietti; Federica Piro; Alda Quattrone; Olimpia Barbato; Gabriele Brecchia
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

3.  Randomized controlled clinical trial on the effect of oral immunoglobulin supplementation on neonatal dairy calves with diarrhea.

Authors:  James J Chung; Maire C Rayburn; Munashe Chigerwe
Journal:  J Vet Intern Med       Date:  2019-05-24       Impact factor: 3.333

Review 4.  Nutritional Feeding Strategies in Pediatric Intestinal Failure.

Authors:  Joanne Olieman; Wendy Kastelijn
Journal:  Nutrients       Date:  2020-01-08       Impact factor: 5.717

Review 5.  Colostrum Therapy for Human Gastrointestinal Health and Disease.

Authors:  Kanta Chandwe; Paul Kelly
Journal:  Nutrients       Date:  2021-06-07       Impact factor: 5.717

Review 6.  Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease.

Authors:  John K Triantafillidis; Maria Tzouvala; Eleni Triantafyllidi
Journal:  Nutrients       Date:  2020-04-10       Impact factor: 5.717

7.  Network-Based Selection of Candidate Markers and Assays to Assess the Impact of Oral Immune Interventions on Gut Functions.

Authors:  Marjolein Meijerink; Tim J van den Broek; Remon Dulos; Jossie Garthoff; Léon Knippels; Karen Knipping; Lucien Harthoorn; Geert Houben; Lars Verschuren; Jolanda van Bilsen
Journal:  Front Immunol       Date:  2019-11-13       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.